Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Sainz

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Cancers|February 12, 2021
Inhibition of Mitochondrial Dynamics Preferentially Targets Pancreatic Cancer Cells with Enhanced Tumorigenic and Invasive PotentialSarah Courtois, Beatriz de Luxán-Delgado, Laure Penin-Peyta, et al.
Cancers|August 7, 2021
Correction: Earl et al. Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival. <i>Cancers</i> 2021, <i>13</i>, 1612Julie Earl, Emma Barreto, María E Castillo, et al.
Gut|April 19, 2015
The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cellsMichele Cioffi, Sara M Trabulo, Yolanda Sanchez-Ripoll, et al.
International Journal of Nanomedicine|May 4, 2026
Evaluation of Self-Illuminating Nanoconjugates Against Pancreatic Ductal AdenocarcinomaMarcelina Abal-Sanisidro, Laura Ruiz-Cañas, Sandra Batres-Ramos, et al.
Cell Metabolism|September 15, 2015
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem CellsPatricia Sancho, Emma Burgos-Ramos, Alejandra Tavera, et al.
Scientific Reports|July 26, 2017
Reduced expression of the murine HLA-G homolog Qa-2 is associated with malignancy, epithelial-mesenchymal transition and stemness in breast cancer cellsIstéfani L da Silva, Lucía Montero-Montero, Ester Martín-Villar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 23, 2023
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survivalMaria Urbanova, Marina Cihova, Verona Buocikova, et al.
Cancers|July 9, 2020
Induction of Lysosome Membrane Permeabilization as a Therapeutic Strategy to Target Pancreatic Cancer Stem CellsTimothy P Cash, Sonia Alcalá, María Del Rosario Rico-Ferreira, et al.
Nature Methods|September 29, 2014
Intracellular autofluorescence: a biomarker for epithelial cancer stem cellsIrene Miranda-Lorenzo, Jorge Dorado, Enza Lonardo, et al.
Pharmaceutics|April 28, 2023
An Aptamer against MNK1 for Non-Small Cell Lung Cancer TreatmentRebeca Carrión-Marchante, Celia Pinto-Díez, José Ignacio Klett-Mingo, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Cancers|February 12, 2021
Inhibition of Mitochondrial Dynamics Preferentially Targets Pancreatic Cancer Cells with Enhanced Tumorigenic and Invasive PotentialSarah Courtois, Beatriz de Luxán-Delgado, Laure Penin-Peyta, et al.
Cancers|August 7, 2021
Correction: Earl et al. Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival. <i>Cancers</i> 2021, <i>13</i>, 1612Julie Earl, Emma Barreto, María E Castillo, et al.
Gut|April 19, 2015
The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cellsMichele Cioffi, Sara M Trabulo, Yolanda Sanchez-Ripoll, et al.
International Journal of Nanomedicine|May 4, 2026
Evaluation of Self-Illuminating Nanoconjugates Against Pancreatic Ductal AdenocarcinomaMarcelina Abal-Sanisidro, Laura Ruiz-Cañas, Sandra Batres-Ramos, et al.
Cell Metabolism|September 15, 2015
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem CellsPatricia Sancho, Emma Burgos-Ramos, Alejandra Tavera, et al.
Scientific Reports|July 26, 2017
Reduced expression of the murine HLA-G homolog Qa-2 is associated with malignancy, epithelial-mesenchymal transition and stemness in breast cancer cellsIstéfani L da Silva, Lucía Montero-Montero, Ester Martín-Villar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 23, 2023
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survivalMaria Urbanova, Marina Cihova, Verona Buocikova, et al.
Cancers|July 9, 2020
Induction of Lysosome Membrane Permeabilization as a Therapeutic Strategy to Target Pancreatic Cancer Stem CellsTimothy P Cash, Sonia Alcalá, María Del Rosario Rico-Ferreira, et al.
Nature Methods|September 29, 2014
Intracellular autofluorescence: a biomarker for epithelial cancer stem cellsIrene Miranda-Lorenzo, Jorge Dorado, Enza Lonardo, et al.
Pharmaceutics|April 28, 2023
An Aptamer against MNK1 for Non-Small Cell Lung Cancer TreatmentRebeca Carrión-Marchante, Celia Pinto-Díez, José Ignacio Klett-Mingo, et al.
Pageof 10